Serum Malondialdehyde Concentration and Glutathione Peroxidase Activity in a Longitudinal Study of Gestational Diabetes by Arribas, Luis et al.
RESEARCH ARTICLE
SerumMalondialdehyde Concentration and
Glutathione Peroxidase Activity in a
Longitudinal Study of Gestational Diabetes
Luis Arribas1☯, Inmaculada Almansa2☯, María Miranda2, María Muriach3, Francisco
J. Romero4*, Vincent M. Villar2
1 Unidad de Diabetes, Servicio de Medicina Interna, Hospital de La Plana, Vila-real, Spain, 2 Dept. Ciencias
Biomédicas, Universidad CEU Cardenal Herrera, Valencia, Spain, 3 Dept. Medicina, Universidad Jaume I,
Castelló, Valencia, Spain, 4 Facultad de Medicina, Universidad Católica de Valencia “San Vicente Martir”,
Valencia, Spain




The main goal of this study was to evaluate the presence of oxidative damage and to quan-
tify its level in gestational diabetes.
Methods
Thirty-six healthy women and thirty-six women with gestational diabetes were studied in the
three trimesters of pregnancy regarding their levels of oxidative stress markers. These
women were diagnosed with diabetes in the second trimester of pregnancy. Blood glucose
levels after 100g glucose tolerance test were higher than 190, 165 or 145 mg/dl, 1, 2 or 3
hours after glucose intake.
Results
The group of women with gestational diabetes had higher serum malondialdehyde levels,
with significant differences between groups in the first and second trimester. The mean val-
ues of serum glutathione peroxidase activity in the diabetic women were significantly lower
in the first trimester. In the group of women with gestational diabetes there was a negative
linear correlation between serum malondialdehyde concentration and glutathione peroxi-
dase activity in the second and third trimester.
Conclusions
In this observational and longitudinal study in pregnant women, the alterations attributable
to oxidative stress were present before the biochemical detection of the HbA1c increase.
Usual recommendations once GD is detected (adequate metabolic control, as well as any
other normally proposed to these patients) lowered the concentration of malondialdehyde
PLOSONE | DOI:10.1371/journal.pone.0155353 May 26, 2016 1 / 13
a11111
OPEN ACCESS
Citation: Arribas L, Almansa I, Miranda M, Muriach
M, Romero FJ, Villar VM (2016) Serum
Malondialdehyde Concentration and Glutathione
Peroxidase Activity in a Longitudinal Study of
Gestational Diabetes. PLoS ONE 11(5): e0155353.
doi:10.1371/journal.pone.0155353
Editor: Reza Khodarahmi, Kermanshah University of
Medical Sciences, ISLAMIC REPUBLIC OF IRAN
Received: December 14, 2015
Accepted: April 27, 2016
Published: May 26, 2016
Copyright: © 2016 Arribas et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: The authors received no specific funding
for this work.
Competing Interests: The authors have declared
that no competing interests exist.
at the end of pregnancy to the same levels of the healthy controls. Serum glutathione perox-
idase activity in women with gestational diabetes increased during the gestational period.
Introduction
Although oxidants and antioxidants have been studied extensively in Type II Diabetes and its
complications, only limited data are available for Gestational Diabetes (GD), a disease of simi-
lar pathophysiology.
In patients with diseases that complicate pregnancy, several elevated markers of oxidative
stress have been found [1–3]. Chen and collaborators [4] detected in a prospective study of 408
healthy pregnant women that the glutathione peroxidase (GPx) activity in erythrocytes of the
16th and 30th week of pregnancy, positively correlated with insulin-resistance markers, suggest-
ing a relationship between resistance to insulin and antioxidant defence in a non-diabetic preg-
nant woman, though it is still unclear which type of relationship exists between diabetes and
oxidative stress [5–10].
Several in vitro studies have used placental tissue to measure oxidative stress after the GD
diagnosis was performed [11–14]. Coughlan et al [11] found that the 8-isoprostane release by
the placenta increased 2-fold in women with GD with respect to the healthy group. The same
research group [12] showed that the placenta of women with GD exposed to Superoxide-Gen-
erating Systems (xanthine and xanthine oxidase) have a reduced response to oxidative stress.
Similarly, Lappas and coworkers [13] showed that placenta, fat and muscle tissues released,
upon incubation, more 8-isoprostane in women with GD than in healthy ones.
There are some evidences which suggest that oxidative stress in GD is accompanied by
changes in the antioxidant capacity [15–19]. Kamath et al. collected maternal erythrocytes
immediately after giving birth and found that the proteolytic activity, which is an indicator of
protein oxidation, was increased in women with GD, and that malondialdehyde (MDA) con-
centration in erythrocytes was higher in GD but not significantly different with respect to the
healthy women [20].
Peuchant et al. showed how the maternal plasmatic MDA concentration was increased and
the erythrocytic GPx activity was diminished in GD as well as in type I diabetes, between weeks
26 and 32 of gestation [17]. Nevertheless, there was no difference in erythrocytic and plasmatic
GPx and catalase activities or thiobarbituric acid reactive substances (TBARS) concentration
during the third trimester. Toescu and co-workers [15] reported a longitudinal study by trimes-
ters, and found that the plasmatic and lipid hydroperoxides were higher in each trimester for
women with type I, type II and GD, compared with the pregnant control group, but the antiox-
idant capacity was significantly decreased. Epidemiological data also support the relationship
between the plasmatic decrease of vitamin C concentration and the increased risk of showing
symptoms of GD [21].
The level of maternal glycemic control has been correlated with several markers of oxidative
stress in GD: erythrocytic MDA content with glycosylated haemoglobin HbA1c [17], and
8-isoprostane in placenta with maternal glycemia 2 hours after the oral glucose tolerance test
(OGTT) [11].
The decrease of antioxidant defence reported in studies of women with GD could indicate
the consumption effect exerted by the already existing oxidative stress.17 It is not clear if the
level of glycemic control in GD is associated with the severity of oxidative stress as it occurs in
type II diabetes [22].
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The main purpose of the present study was to evaluate if there was oxidative damage and, if
so, to measure its extent in gestational diabetes.
Methods
Subjects
We screened 808 pregnant women during the first trimester of pregnancy. All procedures per-
formed were in accordance with the ethical standards of the institutional and/or national
research committee and with the 1964 Helsinki declaration and its later amendments or com-
parable ethical standards. Study was approved by the Institutional Review Board of the Univer-
sidad CEU Cardenal Herrera on May 2001. Only 16% (126 women) completed the study
during the whole pregnancy. Women with a history of diabetes before pregnancy or with pre-
existing hypertension, urinary infections, renal disease, autoimmune disorders, hypothyroid-
ism or any other type of disorder, and smokers were excluded from this work, so only 8.9% (72
women) were suitable for the present study, none of the women had an acute disease or clinical
complication during pregnancy.
We screened for GD in all nondiabetic pregnant women using a two-step standard protocol.
At 24–28 weeks, all pregnant women without previously diagnosed diabetes were offered
screening for GD with a 1-h 50 g glucose challenge test during a routine prenatal visit. A value
of 140 mg/dL (7.8 mmol/L) identified patients who undergo a 3 h 100 g diagnostic OGTT. GD
was diagnosed when two or more plasma glucose values during the diagnostic OGTT met or
exceeded the criteria for a positive test, as recommended by the National Diabetes Data Group
(plasma glucose thresholds: fasting 5.8mmol/L (105 mg/dL), 1-h 10.5 mmol/L (190 mg/dL),
2-h 9.1 mmol/L (165 mg/dL), 3-h 8.0 mmol/l (145 mg/dL)). All pregnant women and GD
patients were advised to control caloric intake and GD patients additionally to monitor blood
glucose levels [23].
Thirty six healthy pregnant women (age-matched healthy pregnant women served as con-
trols) and thirty seven women with GD, diagnosed in the 2nd trimester were studied in the
three trimesters of pregnancy regarding their levels of oxidative stress markers (blood samples
were taken during weeks 12–14, 24–26 and 36–40 of pregnancy in fasting conditions). All of
them gave written informed consent to participate in the study. All of them received the same
polivitaminic treatment and the same dietary recommendations and performed the same phys-
ical exercise. There were no statistically significant differences in maternal age, parity and sex
and in the body weight of the newborns (Table 1). Women with twin pregnancy were excluded
from the study.
Biochemical assays
Seric MDA concentration, a lipid peroxidation product, was determined by liquid chromatog-
raphy according to a modification of the method of Richard et al. [24] as previously described
[25]. Briefly, 0.1 ml of sample (or standard solutions prepared daily from 1,1,3,3-tetramethoxy-
propane and 0.75 ml of working solution (thiobarbituric acid 0.37% and perchloric acid 6.4%,
2:1, v/v) were mixed and heated to 95°C for 1 h. After cooling (10 min in ice-water bath), the
flocculent precipitate was removed by centrifugation (3200 g, 10 min). The supernatant was
neutralized and filtered (0.22 μm) before injection on an ODS 5-μm column (250×4.6mm).
Themobile phase consisted in 50 mM phosphate buffer, pH 6.0: methanol (58:42, v/v). Isocratic
separation was performed at 1.0 ml /min flow (HPLC System 325; Kontron, Germany) and
detection at 532 nm (UV/Vis HPLC Detector 332; Kontron, Germany). Calibration curves
were run daily. GPx activity in serum was assayed as reported by Lawrence et al. [26] towards
hydrogen peroxide. The oxidation of NADPH was followed spectrophotometrically at 340 nm.
Gestational Diabetes and Oxidative Stress
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The reaction mixture consisted of 240 mU/ml glutathione disulfide reductase, 1 mM GSH, 0.15
mMNADPH in 0.1 M potassium phosphate buffer, pH 7.0, containing 1 mM EDTA and 1
mM sodium azide; 50-μl samples were added to this mixture and allowed to equilibrate at 37°C
for 3 min. Reaction was started by the addition of 1.5 mM hydrogen peroxide to adjust the
final volume of the assay mixture to 1 ml.
Statistical Analysis
All data are expressed as mean ± SD. The study of the relationship of the categorical variables
was performed using the Pearson’s Chi-squared test, and the two-tailed Fisher’s exact test to
improve statistical significance when the sample number is small as is this case (smaller that
50). Pearson’s linear regression analysis was used.
The Mann-Whitney U test for not normally distributed data was used, and Student’s t test
for other continuous data. In the case of comparing one of the variables with more than two
categories, with a continuous one, Kruskal-Wallis non-parametric test was used, comparing
afterwards each pair with the Mann-Whitney test but applying the Tukey’s range test. Relative
risks and 95 percent confidence intervals were calculated with SPSS software package version
12.0.1 (SPSS Inc. 2004, Chicago, IL, USA).
Results
As it can be seen in Table 1 the two study groups were similar in the principal demographic
and clinical characteristics. All women belonged to the same race, all were Caucasian.
Table 1. Demographic characteristics of healthy pregnant and diabetes pregnant women (GD).
Variables Mean ± SD CI 95%
Lower limit Upper limit p value
Mother age (years) GD 32.86 ± 4.26 31.42 34.30 ns
Control 29.70 ± 4.64 28.05 31.34
BMI (kg/m2) GD 27.3 ± 9.9 24.2 31.5 ns
Control 24.4 ± 3.9 23.1 26.1
Weight gain (kg) GD 10.0 ± 0.35 9.8 10.4 ns
Control 9.7 ± 0.043 9.6 9.9
Gestation length (days) GD 275.03± 11.54 271.12 278.93 ns
Control 278.85± 11.47 274.78 282.92
Newborn weight (g) GD 3178.61 ± 542.50 2995.05 3362.16 ns
Control 3287.15 ± 517.38 3100.61 3473.69
Newborn sex M/W GD 19(52.8%)/17 (47.2%) ns
Control 21(58.4%)/15(41.6%)
Delivery start (I/S) GD 24 (66.6%)/12 (33.4%) ns
Control 26 (72.2%)/10 (27.8%)
Delivery type (V/C) GD 26 (72.2%)/10 (27.8%) ns
Control 27(75%)/9 (25%)
Parity GD 1.6 0.8 1 3 ns
Control 1.8 0.7 1 3
All women (36 women each group) belonged to the same race, all were Caucasian. (CI = conﬁdence interval; ns = not signiﬁcant; BMI = body mass index;
M/W = male/women; I/S = induced/spontaneous; V/C = vaginal/caesarean). Values are given as mean ± standard deviation.
doi:10.1371/journal.pone.0155353.t001
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The HbA1c levels were similar for both groups of women in the first trimester (before diabe-
tes started), but significantly higher in the GD group in the second and third trimester than in
healthy subjects (Fig 1).
The mean values of MDA concentration were higher in the GD group during the whole
period of gestation, with significant differences in the first and second trimesters with respect
to the control group (Fig 2). Surprisingly, MDA levels of the GD group in the third trimester
decreased to control values. The mean values of GPx activity for the diabetic women were
always lower, with statistically significant differences in the first trimester respect to the control
group (Fig 3). Moreover, GPx activity showed statistically significant differences in the GD
group between the first and the following trimesters.
The correlation study through Pearson's chi-square test showed that in the GD group there
was a negative linear correlation between MDA levels and GPx activity in the second and third
Fig 1. Percentage of Glycosylated Hemoglobin (HbA1c) in both groups of women (control and
diabetic women) in the three trimesters of gestation.Data are expressed as mean ± SD (* p < 0.05
versus control).
doi:10.1371/journal.pone.0155353.g001
Fig 2. Mean values of MDA concentration in both groups of women (healthy and diabetic women) in the three
trimesters of gestation.Data are expressed as mean ± SD (* p < 0.05 versus control).
doi:10.1371/journal.pone.0155353.g002
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trimesters (p<0.05, r = -0.494, and p<0.05, r = -0.594) respectively (Fig 4B and 4D), whereas
in the control group this negative linear correlation was not significant in the second and third
trimesters (p>0.05, r = -0.384, and p>0.05, r = -0.193) (Fig 4A and 4C). When the GD and the
control groups were evaluated together during the whole gestation, a direct correlation between
MDA concentration and percentage of HbA1c was found (Fig 5) and an indirect one between
GPx activity and HbA1c percentage were found (Fig 6).
The lipidic profiles of the patients were studied, and our results coincided with previously
published data. Pregnancy progressively increases all the lipid components with no significant
differences between groups of healthy and pregnant women with GD (Table 2) and there was
no correlation between lipidic values and MDA concentration or GPx activity (data not
shown).
Discussion
The main purpose of this study was to prove the existence of oxidative stress along pregnancy
in GD by means of a longitudinal study. GD was approached by dividing it in three phases: the
euglycemic one in the first trimester (before the GD diagnosis is performed), the starting
hyperglycemia in the second trimester (in the moment of diagnosis, still without applying any
treatment), and eventually the response to treatment in the third trimester. This study supports
the hypothesis that there is an extra oxidative stress in GD, which could be counteracted by its
treatment which then can significantly improve the outcome of pregnancy.
The percentage of HbA1c values in healthy pregnant women are lower than in the non-
pregnant ones, but there has been some controversy about the time course of these values dur-
ing pregnancy [27]. Some authors do not find statistically significant differences throughout
the whole period of pregnancy [27], other authors find decreases [28, 29], and still others find
increases during the third trimester [30, 31]. In our study both groups of pregnant women
showed a small increase in HbA1c in the 2nd trimester compared to the first one, though only
the GD group reached statistical significance (Fig 1), most probably due to an increase in the
average postprandial glycemia. GD group HbA1c percentage values in the 3rd trimester were
Fig 3. Mean values of Glutathione-Peroxidase (GPx) activity in both groups of women (healthy and
diabetic women) in the three trimesters of gestation. Data are expressed as mean ± SD (*p < 0.05 versus
control).
doi:10.1371/journal.pone.0155353.g003
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lower than those of the 2nd trimester and different from their control groups (p< 0.05), attrib-
utable to a decrease in the life span of the erythrocytes, and a decrease in the average and pre-
prandial glycemia.
Oxidative stress in healthy pregnant women
MDA concentration and GPx activity in the control group herein did not show variation dur-
ing pregnancy. Both parameters develop in a parallel way (Fig 2 and Fig 3). A majority of the
studies on lipid peroxidation that compare healthy pregnant with non-pregnant women found
higher levels in the pregnant group [32–34], with ratios between 1.08 and 3.04, with no rela-
tionship between the marker and the amount of the increase. Obviously a normal pregnancy is
a condition with higher oxidative aggressions, being the placenta one of its sources [11, 35],
post-delivery studies show a decrease of the markers already in the first days following delivery
[36].
Longitudinal studies allow us to study oxidative stress along pregnancy. Some authors
described progressive increases during pregnancy with significant differences in the second
and/or third trimester with respect to the beginning of pregnancy [33, 36–39], other authors
did not show any difference during the whole period of pregnancy [40–42].
Fig 4. Correlation study through Pearson's linear regression analysis in the second and third
trimester. (A) Correlation between MDA concentration and GPx activity in the second trimester at control
group (p > 0.05, r = -0.384). (B) Correlation between MDA concentration and GPx activity in the second
trimester at gestational diabetes group (p < 0.05, r = -0.494). (C) Correlation between MDA concentration and
GPx activity in the third trimester at control group (p > 0.05, r = -0.193). (D) Correlation between MDA
concentration and GPx activity in the third trimester at gestational diabetes group (p < 0.05, r = -0.594).
doi:10.1371/journal.pone.0155353.g004
Gestational Diabetes and Oxidative Stress
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In the present study GPx activity in healthy pregnant women remain stable during the three
trimesters, showing a small non-significant decrease in the second trimester (Fig 3). The activ-
ity of the antioxidant enzymes (GPx and SOD in plasma and erythrocytes) and other related
substances (selenium and glutathione) are normally diminished with respect to the non-preg-
nant women [16, 33, 34]. Towards the end of the pregnancy the values are more diverse among
different authors: some showed increases [4, 39, 41], others showed decreases [16, 33], and
even others did not show any change with respect to the beginning of pregnancy [2, 37, 38, 43].
The big methodological differences among all these reports make it difficult to compare them.
Some suggested that the increase of the antioxidant markers could indicate the effort of the sys-
tem to balance the oxidative damage, i.e. up-regulation of the globular form of serum GPx
activity as a compensatory mechanism to counteract increased steady-state levels of activated
species, and eventually the depletion of the existing resources.
Oxidative stress in GD
MDA plasmatic concentrations in the GD group did not show significant variations during the
first two trimesters of pregnancy (Fig 2). GPx plasmatic activity during the first trimester is sig-
nificantly lower than the other trimesters, remaining constant in the second half of pregnancy
(Fig 3). The GD group showed higher values of MDA concentration during the whole
Fig 5. Correlation study through Pearson's linear regression analysis in all women betweenMDA
concentration and percentage of HbA1c (p < 0.05, r = 0.325).
doi:10.1371/journal.pone.0155353.g005
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pregnancy with significant differences in the first and the second trimesters, i.e. before and dur-
ing diagnosis, and before therapeutic measures were adopted. GPx activities were always lower
with significant differences in the first trimester. The first trimester was characterized by eugly-
cemia in both groups and similar levels of HbA1c percentage. The women who will develop
GD show higher MDA concentration and lower GPx activity than the ones in the control
group, with significant differences, suggesting oxidative stress involvement in the pathogenesis
of GD. We have detected a significant direct correlation between MDA concentrations and per-
centage of HbA1c (Fig 5) so it would be possible that oxidative stress levels may be correlated
with glycemia in this phase.
During the second trimester a GD metabolic distress develops, but no treatment is received
at that time. HbA1c levels increases significantly and MDA concentration shows statistically
significant difference among groups. Simultaneously GPx activity increases and the differences
among groups disappear so, as mentioned above we hypothesize that there would be an
increase in GPx expression, and therefore in its activity, as an attempt to compensate for the
steady state levels of activated species.
Finally, in the third trimester, when the conventional dietary recommendations are applied,
glycemic control improves and percentage of HbA1c levels diminish, MDA levels decreased to
control values, and GPx activity remains constant. Inverse correlations between serum MDA
concentration and GPx activity are found at GD group in the 2nd and 3rd trimesters (Fig 4B
and Fig 4D): higher MDA values are correlated with lower GPx activities probably due to the
Fig 6. Correlation study through Pearson's linear regression analysis in all women between GPx
activity and percentage of HbA1c (p < 0.05, r = 0.303).
doi:10.1371/journal.pone.0155353.g006
Gestational Diabetes and Oxidative Stress
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adverse effects of lipid peroxidation products on GPx activity when all data were taken together
[44].
Ours is the only study in which women with GD were monitored during the whole period
of pregnancy. Wender-Ozegowska et al. [45] studied pregnant women with type I diabetes and
showed that there were no changes in MDA concentrations during pregnancy in the group of
mothers with a satisfactory glycemic control. Santra showed higher significant MDA concen-
trations than the control ones, from gestational week 31, and repeating the analysis each four
Table 2. Biochemical variables of the two groups studied (36 women each group), healthy pregnant and diabetes pregnant women (GD).
Variables Mean ± SD CI 95%
Lower limit Upper limit p value
Hb A1c (%) 1st trimester Control 4.1±0.3 4.02 4.26 ns
GD 4.2±0.4 3.98 4.49
2ndtrimester Control 4.2±0.6 4.04 4.46 p<0.001
GD 4.8±0.6 4.59 5.02
3rd trimester Control 4.1±0.4 3.91 4.19 p<0.001
GD 4.5±0.4 4.42 4.75
Total cholesterol (mg/dl) 1st trimester Control 184.6±39.1 165.04 202.71 ns
GD 172.5±23.4 162.34 182.22
2ndtrimester Control 226.3±38.1 209.21 245.76 ns
GD 226.1±30.2 211.43 239.71
3rd trimester Control 264.2±40.6 274.95 283.33 ns
GD 265.6±38.1 248.03 281.16
LDL cholesterol (mg/dl) 1st trimester Control 92.8±21.8 82.37 102.67 ns
GD 85.1±24.1 75.82 94.33
2ndtrimester Control 117.3±24.9 105.20 128.19 ns
GD 114.8±32.9 100.61 128.51
3rd trimester Control 142.8±32.8 129.41 155.81 ns
GD 144.5±41.2 126.69 163.36
HDL colesterol (mg/dl) 1st trimester Control 68.3±17.4 62.01 78.43 ns
GD 64.8±15.3 57.21 70.44
2ndtrimester Control 73.1±18.3 66.71 82.21 ns
GD 70.1±15.5 65.99 79.32
3rd trimester Control 79.4±17.5 72.12 86.37 ns
GD 76.4±16.3 69.60 83.67
Triglycerides (mg/dl) 1st trimester Control 88.3±54.1 63.02 111.04 ns
GD 83.9±32.7 67.36 94.51
2ndtrimester Control 152.1±47.6 131.82 170.32 ns
GD 152.6±42.1 133.34 170.27
3rd trimester Control 206.1±70.5 171.49 220.15 ns
GD 225.3±61.1 208.93 260.71
Fasting blood Glucose (mg/dl) 1st trimester Control 83.1±6.1 80.99 85.24 ns
GD 90.3±8.8 87.35 93.32
2ndtrimester Control 76.9±6.3 74.72 79.10 ns
GD 87.2±9.9 83.91 90.65
3rd trimester Control 77.1±7.7 74.44 79.79 ns
GD 83.9±12.2 79.77 88.06
Values are given as mean ± standard deviation.
doi:10.1371/journal.pone.0155353.t002
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weeks in the 3rd trimester, but values of glycemia or HbA1c were not studied, and furthermore,
patients with preeclampsia were present in both groups [46], making the data interpretation
more difficult.
There are different ways to understand the antioxidant capacity in GD, due to the several
analytical methods which have been employed: high vitamin E levels have been described [46]
as well as low antioxidant capacity [15]. Peuchant described significant lower values in erythro-
cytic GPx in GD and no significant differences in erythrocytic SOD [17], but other authors
showed a decrease in erythrocytic SOD [18].
Lipid peroxidation has been related to alterations of prostaglandin synthesis which could be
responsible for the fetal malformations attributed to diabetes. Our study does not include bio-
chemical data of the newborn but we did not observe differences in their weight or in congeni-
tal malformations (data not shown), as a consequence of a disturbed metabolic control. Even
though percentage of HbA1c is significantly higher in the GD group in the 2nd and 3rd trimes-
ter, these levels are within the recommended range.
Peuchant found a positive correlation between HbA1c and free erythrocytic MDA in the
whole group of pregnant women with diabetes (type I diabetes women plus women with GD)
at the beginning of the third trimester [17], but not in each group by itself. In our study when
we evaluated the GD and the control groups together, a direct correlation between MDA con-
centration and percentage of HbA1c was found (Fig 5) and indirect correlations between GPx
activity and HbA1c percentage (Fig 6), and between GPx activity and MDA concentration
(Fig 4) as well, suggesting certain degree of association between pregnancy and oxidative stress.
Herein we can consider the possibility of predicting GD with the oxidative stress markers
evaluated. An early GD diagnosis would be necessary to minimize the fetal exposure to subop-
timal metabolic conditions and prevent perinatal complications. Our data on oxidative stress
show significant differences among groups at the beginning of pregnancy, i.e. before GD diag-
nosis. Further and larger series would be necessary to confirm the predictive value of this assay.
Limitations of the study
808 patients were screened during 1st trimester of pregnancy and only 36 patients per group
were studied. Although this is certainly a weakness of this study, the data herein represent one
of the largest series studied for oxidative stress markers in gestational diabetes. To ascertain
that the usual vitamin supplements recommended play a role in the amelioration of oxidative
stress markers, the blood levels of those vitamins could have been mentioned. However, since
both groups were offered the same protocol (exercise, diet and vitamin supplements) this bias
if any, applies to both groups.
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